GASTROENTEROLOGY MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

Key Developments

• On August 23, 2024, Indian gastroenterologists launched the Gastro AI Academy to offer free AI education to GI physicians and surgeons, aiming to enhance patient care through advanced technology. FUJIFILM India partnered in this initiative. Dr. Amit Maydeo of HN Reliance Hospital highlighted AI's transformative role in Gastroenterology, noting its potential to improve patient outcomes and prepare the next generation of gastroenterologists with essential skills for the future.
• In April 2024, OMNY Health partnered with leading community-based gastroenterology practices and integrated delivery networks to launch innovative real-world data solutions for research. This expansion adds over 5,000 GI providers serving more than 10 million patients to OMNY's network, which now includes data from 380,000 providers and 75 million patients across the U.S. OMNY's platform integrates de-identified EHRs to provide insights into patient care, treatment outcomes, and the impact of social determinants, supporting large-scale, compliant research partnerships.
• In February 2024, Salvo Health, a gastrointestinal care startup, secured USD 5 million in a Seed Prime funding round led by City Light Capital and Human Ventures. The company, which operates a virtual care clinic for individuals with chronic gut conditions, plans to use the funds to expand its services and provider network.
• In March 2024, Johnson & Johnson submitted a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) for the approval of TREMFYA (guselkumab) to treat adults with moderately to severely active ulcerative colitis (UC)